FR2715937B1 - - Google Patents

Info

Publication number
FR2715937B1
FR2715937B1 FR9401532A FR9401532A FR2715937B1 FR 2715937 B1 FR2715937 B1 FR 2715937B1 FR 9401532 A FR9401532 A FR 9401532A FR 9401532 A FR9401532 A FR 9401532A FR 2715937 B1 FR2715937 B1 FR 2715937B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9401532A
Other languages
French (fr)
Other versions
FR2715937A1 (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9401532A priority Critical patent/FR2715937A1/en
Application filed filed Critical
Priority to JP52042695A priority patent/JP3611856B2/en
Priority to DE0674004T priority patent/DE674004T1/en
Priority to EP95420027A priority patent/EP0674004B1/en
Priority to NZ279855A priority patent/NZ279855A/en
Priority to ES95420027T priority patent/ES2233936T3/en
Priority to PCT/FR1995/000142 priority patent/WO1995021256A1/en
Priority to US08/384,137 priority patent/US5871996A/en
Priority to AU17114/95A priority patent/AU704440B2/en
Priority to CA002141907A priority patent/CA2141907A1/en
Priority to AT95420027T priority patent/ATE285475T1/en
Priority to DE69533863T priority patent/DE69533863T2/en
Priority to US08/471,724 priority patent/US5800980A/en
Priority to US08/470,006 priority patent/US5962217A/en
Priority to US08/471,969 priority patent/US5871745A/en
Publication of FR2715937A1 publication Critical patent/FR2715937A1/en
Priority to FI954699A priority patent/FI954699A/en
Priority to NO953925A priority patent/NO953925L/en
Publication of FR2715937B1 publication Critical patent/FR2715937B1/fr
Application granted granted Critical
Priority to US09/133,411 priority patent/US6342383B1/en
Priority to US09/200,990 priority patent/US6184025B1/en
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
FR9401532A 1899-02-04 1994-02-04 Two pathogenic or infectious agents associated with multiple sclerosis Granted FR2715937A1 (en)

Priority Applications (19)

Application Number Priority Date Filing Date Title
FR9401532A FR2715937A1 (en) 1994-02-04 1994-02-04 Two pathogenic or infectious agents associated with multiple sclerosis
DE69533863T DE69533863T2 (en) 1994-02-04 1995-02-06 MSRV1 virus associated with multiple sclerosis, its nuclear constituents and uses
DE0674004T DE674004T1 (en) 1994-02-04 1995-02-06 MSRV1 virus and contagious and / or disease-causing MSRV2 associated with multiple sclerosis, their nuclear components and uses.
NZ279855A NZ279855A (en) 1994-02-04 1995-02-06 Msrv1 and msrv2 pathogenic and/or infectious agents associated with ms, nucleic acids encoding them and diagnostic and therapeutic applications
ES95420027T ES2233936T3 (en) 1994-02-04 1995-02-06 VIRUS MSRV1 ASSOCIATED WITH SCLEROSIS IN PLATES, ITS NUCLEIC CONSTITUENTS AND ITS APPLICATIONS.
PCT/FR1995/000142 WO1995021256A1 (en) 1994-02-04 1995-02-06 Msrv1 virus and msrv2 pathogenic and/or infectious agent associated with multiple sclerosis, nucleic acid components and applications of same
US08/384,137 US5871996A (en) 1994-02-04 1995-02-06 Retrovirus agents MSRV1 and MSRV2 associated with multiple sclerosis
AU17114/95A AU704440B2 (en) 1994-02-04 1995-02-06 MSRV1 virus and MSRV2 pathogenic and/or infectious agent associated with multiple sclerosis, nucleic acid components and applications of same
CA002141907A CA2141907A1 (en) 1994-02-04 1995-02-06 Virus msrvl and pathogen agent and/or msrv2 associated with multiple sclerosis, their nucleic constituants and their applications
AT95420027T ATE285475T1 (en) 1994-02-04 1995-02-06 MSRV1 VIRUS ASSOCIATED WITH MULTIPLE SCLERosis, ITS NUCLEAR COMPONENTS AND USES
JP52042695A JP3611856B2 (en) 1994-02-04 1995-02-06 MSRV1 virus and MSRV2 pathogenic and / or infectious agents involved in multiple sclerosis, nucleic acid components and applications thereof
EP95420027A EP0674004B1 (en) 1994-02-04 1995-02-06 MSRV1 virus linked to multiple sclerosis, its nucleic components and their applications
US08/471,724 US5800980A (en) 1899-02-04 1995-06-06 Detection of MSRV1 virus and MSRV2 pathogen and/or infective agent associated with multiple sclerosis, by nucleic acid hybridization
US08/470,006 US5962217A (en) 1994-02-04 1995-06-06 MSRV1 virus and MSRV2 pathogen and/or infective agent associated with multiple sclerosis, and biopolymer constituents thereof
US08/471,969 US5871745A (en) 1994-02-04 1995-06-06 Multiple sclerosis related virus
FI954699A FI954699A (en) 1994-02-04 1995-10-03 MSRV1 virus and MSRV2 pathogenic and / or infective agents associated with multiple sclerosis, their nucleic acid components and their applications
NO953925A NO953925L (en) 1994-02-04 1995-10-03 MSRV1 virus and MSRV2 pathogenic and / or infectious agent associated with multiple sclerosis, nucleic acid components and their use
US09/133,411 US6342383B1 (en) 1994-02-04 1998-08-13 Cell lines and viral isolates associated with multiple sclerosis
US09/200,990 US6184025B1 (en) 1994-02-04 1998-11-30 Viral isolates associated with multiple sclerosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9401532A FR2715937A1 (en) 1994-02-04 1994-02-04 Two pathogenic or infectious agents associated with multiple sclerosis

Publications (2)

Publication Number Publication Date
FR2715937A1 FR2715937A1 (en) 1995-08-11
FR2715937B1 true FR2715937B1 (en) 1997-02-14

Family

ID=9459973

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9401532A Granted FR2715937A1 (en) 1899-02-04 1994-02-04 Two pathogenic or infectious agents associated with multiple sclerosis

Country Status (1)

Country Link
FR (1) FR2715937A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2762601B3 (en) 1997-04-29 1999-06-04 Bio Merieux POLYPEPTIDE CAPABLE OF RESPONDING TO ANTIBODIES OF PATIENTS WITH MULTIPLE SCLEROSIS AND USES
FR2765588A1 (en) 1997-07-07 1999-01-08 Bio Merieux RETROVIRAL NUCLEIC MATERIAL AND NUCLEOTIDE FRAGMENTS ESPECIALLY ASSOCIATED WITH MULTIPLE SCLEROSIS AND / OR RHUMATOID POLYARTHRITIS, FOR DIAGNOSIS, PROPHYLACTICS AND THERAPEUTICS

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK173091D0 (en) * 1991-10-11 1991-10-11 Schleroseforeningen The Danish BIOLOGICAL MATERIALS
FR2689520B1 (en) * 1992-04-03 1996-07-19 Bio Merieux METHOD AND CULTURE MEDIUM FOR OBTAINING CELLS INFECTED WITH A VIRUS ASSOCIATED WITH MULTIPLE SCLEROSIS.
ES2257734T3 (en) * 1992-05-18 2006-08-01 Genentech, Inc. ACTIVATION OF THE OLIGOMERIZATION RECEIVERS THROUGH THE LEADERS OF FUSED RECEIVERS.
GB9310657D0 (en) * 1993-05-24 1993-07-07 Univ London Retrovirus

Also Published As

Publication number Publication date
FR2715937A1 (en) 1995-08-11

Similar Documents

Publication Publication Date Title
EP0676464A3 (en)
EP0666525A3 (en)
EP0671407A3 (en)
EP0669187A3 (en)
EP0712259A3 (en)
EP0675644A3 (en)
ITMI952210A0 (en)
EP0665261A3 (en)
EP0678287A3 (en)
BR9509661A (en)
EP0667627A3 (en)
FR2715937B1 (en)
FR2721374B1 (en)
FR2724228B1 (en)
FR2728909B1 (en)
ECSDI940198S (en)
CU22450A3 (en)
BR7402097U (en)
IN181525B (en)
ECSDI940187S (en)
CN3025860S (en)
CN3028268S (en)
EP0674909A3 (en)
EP0674854A3 (en)
CN3025122S (en)

Legal Events

Date Code Title Description
ST Notification of lapse